Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Evolus, Inc.
Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia
July 30, 2024
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
May 10, 2024
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
July 26, 2023
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus Announces Expansion into U.S. Dermal Filler Market with Evolysse™, a First-Generation Cold Technology HA by Symatese
May 09, 2023
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus to Report First Quarter 2023 Results and Provide Business Update
May 05, 2023
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus Initiates Nuceiva® Launch in Germany and Austria
February 27, 2023
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus to Participate in the Virtual 11th Annual SVB Leerink Global Healthcare Conference
February 02, 2022
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Net Revenue and Provides 2022 Guidance
January 26, 2022
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Evolus Enters Into $125 Million Credit Facility with Pharmakon Advisors
December 14, 2021
From
Evolus, Inc.
Via
Business Wire
Tickers
EOLS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.